CD19-CAR NK CELLS CO-EXPRESSING IL15/IL15R alpha SHOW ENHANCED CYTOTOXICITY AGAINST B-CELL LEUKEMIA

Author(s)

Silvestre, R. N. ; Eitler, J. ; de Azevedo, J. T. Teixeira Cottas ; Tonn, T. ; Picanco-Castro, V.

• Document type: Journal article
• Source: CYTOTHERAPY; v. 24, n. 5, p. 2-pg., 2022-05-01.
• FAPESP's process: 19/25309-0 - Off-the-shelf engineered NK cells for the treatment of Leukemia and Lymphoma treatment
• Grantee: Virginia Picanço e Castro
• Support Opportunities: Regular Research Grants
• FAPESP's process: 20/08279-8 - Establishment of a platform for generating NK-CAR cells with greater therapeutic effectiveness in vitro and in vivo
• Grantee: Júlia Teixeira Cottas de Azevedo
• Support Opportunities: Scholarships in Brazil - Post-Doctoral
• FAPESP's process: 13/08135-2 - CTC - Center for Cell-Based Therapy
• Grantee: Dimas Tadeu Covas
• Support Opportunities: Research Grants - Research, Innovation and Dissemination Centers - RIDC
• FAPESP's process: 20/07055-9 - Nucleus of Cellular Therapy - NuTeC
• Grantee: Rodrigo do Tocantins Calado de Saloma Rodrigues
• Support Opportunities: Research Grants - Problem-Oriented Research Centers in São Paulo